(30 days)
Not Found
No
The description focuses on specialized HRV measurements and analysis algorithms without mentioning AI or ML. The analysis is described as identifying patterns, which could be rule-based or algorithmic without necessarily involving learning.
No
The device is intended for analysis and reporting of ECG data and heart rate variability (HRV) measurements, not for treatment or therapy. It explicitly states it is not intended to produce any interpretation or diagnosis, and its measurements have not been approved for any specific clinical diagnosis.
No
Explanation: The "Intended Use / Indications for Use" section explicitly states, "HeRO is intended to provide only specialized HRV measurements and is not intended to produce any interpretation of those measurements or any kind of diagnosis." It also mentions that the measurements "have not been approved by the FDA for any specific clinical diagnosis." This indicates it's a data acquisition and analysis tool, not a diagnostic device.
No
The device description explicitly states that HeRO 3.0 is comprised of "off-the-shelf Personal Computers (PC's) and special-purpose hardware capable of acquiring, storing, analyzing, and reporting ECG data". It also mentions a "special-purpose Data Acquisition Device (DAD)" and that the "HeRO-specific hardware has been third-party tested". This indicates the device includes hardware components beyond just software.
Based on the provided information, the HeRO device is not an In Vitro Diagnostic (IVD).
Here's why:
- IVDs analyze samples taken from the human body. The HeRO device acquires and analyzes ECG data, which is a physiological signal measured from the body, not a sample taken from the body (like blood, urine, or tissue).
- The intended use focuses on analyzing ECG data and heart rate variability. This is a form of physiological monitoring and analysis, not laboratory testing of biological samples.
- There is no mention of analyzing biological samples. The description clearly states it acquires data from an ECG monitor.
Therefore, the HeRO device falls under the category of a medical device that analyzes physiological signals, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
HeRO is intended to acquire, store, analyze, and report on ECG data collected from infants. HeRO is intended to be used under the direct supervision of a licensed health care practitioner in a hospital neonatal or pediatric ICU environment.
HeRO is intended to be used for the analysis of the variability in RR intervals (heart rate) and to report measurements of the variability of heart rate data (HRV). The HRV measurements reported by HeRO are specialized in nature, and intended to identify periods of transient decelerations and/or reduced baseline variability in the heart rate.
HeRO is intended to provide only specialized HRV measurements and is not intended to produce any interpretation of those measurements or any kind of diagnosis.
The specialized HRV measurements produced by HeRO have not been approved by the FDA for any specific clinical diagnosis.
HeRO acquires data from a user-supplied ECG monitor, and requires a user-supplied local area network.
Product codes
DPS
Device Description
HeRO 3.0 is comprised of off-the-shelf Personal Computers (PC's) and special-purpose hardware capable of acquiring, storing, analyzing, and reporting ECG data from the cardiac monitoring real-time network. Data is acquired either on a special-purpose Data Acquisition Device (DAD) or via the physiological monitoring network. It is stored and analyzed on a HeRO Server or physiological monitor. Results of the analyses are reported on one or more Viewing Stations. The analysis algorithms identify Heart Rate Variability (HRV) patterns that reflect transient decelerations and/or reduced baseline variability.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
infants
Intended User / Care Setting
licensed health care practitioner in a hospital neonatal or pediatric ICU environment.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
HeRO 3.0 was developed and is manufactured in accordance with 21CFR820 Ouality System Regulations. The HeRO-specific hardware has been third-party tested in accordance with IEC 60601-1 and IEC 60601-1-2. The HeRO 3.0 System performance matches its product specifications.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.2340 Electrocardiograph.
(a)
Identification. An electrocardiograph is a device used to process the electrical signal transmitted through two or more electrocardiograph electrodes and to produce a visual display of the electrical signal produced by the heart.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image shows the logo for Medical Predictive Science Corporation. The logo consists of a stylized graphic to the left, followed by the text "MPSC" in large, bold letters. Below the letters is the full name of the company, "Medical Predictive Science Corporation", in a smaller font. The logo appears to be designed to convey a sense of scientific or medical expertise.
JUL - 8 2011
HeRO 3.0 Special Premarket Notification
Section 5: 510(k) Summary
A. Applicant Tables
| Category | Comments |
|---|---|
| Sponsor: | Medical Predictive Science Corporation |
| 2246 Ivy Rd, Suite 17 | |
| Charlottesville, VA 22903 | |
| Tel: (800) 394 1625 | |
| Correspondent Contact | |
| Information: | William E King |
| CEO | |
| Medical Predictive Sciences Corp. | |
| (434) 220 0714 (Direct) | |
| (240) 220 6098 (FAX) | |
| wking@mpsc.biz | |
| Device Common Name: | Electrocardiograph, HRV Analysis System |
| Device Classification Number: | 21 CFR 870.2340 |
| Device Classification & | |
| Product Code: | Class II, |
| 74 DPS | |
| Device Proprietary Name: | HeRO 3.0 |
| Predicate Device: | HeRO 2.0 |
|---|---|
| Predicate Device Manufacturer: | Medical Predictive Sciences Corp. |
| Predicate Device Common Name: | HRV Analysis System |
| Predicate Device Premarket Notification # | K081473 |
| Predicate Device Classification: | 21 CFR 870.2340 |
| Predicate Device Classification & | Class II, |
| Product Code: | DPS |
B. Date Summary Prepared
June 8th, 2011
C. Description of Device
HeRO 3.0 is comprised of off-the-shelf Personal Computers (PC's) and special-purpose hardware capable of acquiring, storing, analyzing, and reporting ECG data from the cardiac monitoring real-time network. Data is acquired either on a special-purpose Data Acquisition Device (DAD) or via the physiological monitoring network. It is stored and analyzed on a HeRO Server or physiological monitor. Results of the analyses are reported on one or more Viewing Stations. The analysis algorithms identify Heart Rate Variability (HRV) patterns that reflect transient decelerations and/or reduced baseline variability.
1
K111601 P2/2
Image /page/1/Picture/1 description: The image shows the logo for Medical Predictive Science Corporation (MPSC). The logo features a stylized graphic on the left, followed by the letters "MPSC" in large, bold font. Below the letters, the full name of the company, "Medical Predictive Science Corporation," is written in a smaller font size.
D. Indications for Use
Identical to Predicate HeRO 2.0:
HeRO is intended to acquire, store, analyze, and report on ECG data collected from infants. HeRO is intended to be used under the direct supervision of a licensed health care practitioner in a hospital neonatal or pediatric ICU environment.
HeRO is intended to be used for the analysis of the variability in RR intervals (heart rate) and to report measurements of the variability of heart rate data (HRV). The HRV measurements reported by HeRO are specialized in nature, and intended to identify periods of transient decelerations and/or reduced baseline variability in the heart rate.
HeRO is intended to provide only specialized HRV measurements and is not intended to produce any interpretation of those measurements or any kind of diagnosis.
The specialized HRV measurements produced by HeRO have not been approved by the FDA for any specific clinical diagnosis.
HeRO acquires data from a user-supplied ECG monitor, and requires a user-supplied local area network.
E. Comparison to Predicate Device
The application HeRO 3.0 is identical to the predicate HeRO 2.0 in Intended Use, Indications for Use, technology (microprocessor-based), and algorithm for processing Heart Rate data to derive an index Score of Heart Rate Variability HRV).
The devices differ in that the graphical interface for the 3.0 can be produced in several languages, and the HRV can be displayed on the patient's bedside physiological monitor screen. Also, the HeRO 3.0 can accept digital input from a physiological monitor via its software interface or by being resident in the physiological monitor's server.
These changes do not raise new types of safety and effectiveness questions. All changes were fully developed and validated within a design control environment compliant with the FDA's Quality System Requirements.
F. Summary of Supporting Data
HeRO 3.0 was developed and is manufactured in accordance with 21CFR820 Ouality System Regulations. The HeRO-specific hardware has been third-party tested in accordance with IEC 60601-1 and IEC 60601-1-2. The HeRO 3.0 System performance matches its product specifications.
2
Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services USA. The logo consists of a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" arranged around the circumference. Inside the circle is a stylized image of an eagle with its wings spread, formed by three curved lines.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
Medical Predictive Science Corporation c/o Mr. William E King, CEO 2246 Ivy Rd, Suite 17 Charlottesville, VA 22903
JUL - 8 2011
Re: K111601
Trade/Device Name: HeRO 3.0 Regulation Number: 21 CFR 870.2340 Regulation Name: Electrocardiograph Regulatory Class: Class II (two) Product Codes: DPS Dated: June 8, 2011 Received: June 8, 2011
Dear Mr. King:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act
3
Page 2 -- Mr. William E King
or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements. including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if annlicable, the electronic product radiation control provisions (Sections 531-542 of the Act): 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803). please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Image /page/4/Picture/0 description: The image shows the logo for Medical Predictive Science Corporation (MPSC). The logo features a stylized graphic on the left, followed by the letters "MPSC" in large, bold font. Below the letters, the full name of the company, "Medical Predictive Science Corporation," is written in a smaller font.
Section 4: Indications for Use Statement
510(k) Number (if known): K || 16 0 |
Medical Predictive Sciences Corporation, HeRO 3.0 Device Name:
Indications For Use:
HeRO is intended to acquire, store, analyze, and report on ECG data collected from infants. HeRO is intended to be used under the direct supervision of a licensed health care practitioner in a hospital neonatal or pediatric ICU environment.
HeRO is intended to be used for the analysis of the variability in RR intervals (heart rate) and to report measurements of the variability of heart rate data (HRV). The HRV measurements reported by HeRO are specialized in nature, and intended to identify periods of transient decelerations and/or reduced baseline variability in the heart rate.
HeRO is intended to provide only specialized HRV measurements and is not intended to produce any interpretation of those measurements or any kind of diagnosis.
The specialized HRV measurements produced by HeRO have not been approved by the FDA for any specific clinical diagnosis.
HeRO acquires data from a user-supplied ECG monitor, and requires a user-supplied local area network.
| Prescription Use(Part 21, CFR 801 Subpart D) | X | AND/OR |
|---|---|---|
| ---------------------------------------------- | --- | -------- |
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
| Concurrence of CDRH, Office of Device Evaluation (ODE) | |
|---|---|
| Page 1 of | |
| (Division Sign- | |
| Division of Caron | |
| 510(k) Number | K111601 |
| Section 4, Page 1 |